A multicenter, double-blind, placebo-controlled, dose-ranging study to assess the efficacy and safety of doxercalciferol capsules in the treatment of subjects with moderate to severe chronic plaque psoriasis.

Trial Profile

A multicenter, double-blind, placebo-controlled, dose-ranging study to assess the efficacy and safety of doxercalciferol capsules in the treatment of subjects with moderate to severe chronic plaque psoriasis.

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Jun 2014

At a glance

  • Drugs Doxercalciferol (Primary)
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 03 May 2014 The number of treatment arms have been changed from 2 to 4 and drug dosages have been added as reported by ClinicalTrials.gov record.
    • 08 Oct 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top